Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.FGEN · Entity 7431 | SVP, CHINA OPERATIONS | March 06, 2025 | March 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date March 06, 2025 · Filed March 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 294,903 |
Ending reported balance
After 2025-03-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-06 · Tax withholding · Disposed 7,008 · Balance 294,544 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Row 2 · 2025-03-06 · Grant · Acquired 781 · Balance 295,325 F2: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025. Row 3 · 2025-03-06 · Tax withholding · Disposed 422 · Balance 294,903 F3: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
F2: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025.
F3: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2025 Filed Mar 8, 2025 00:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 422 | $0.39 | $164.58 |
DisclosureSEC source: 0001415889-25-007457 · form4-03082025_120324.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,903 F3 · shares: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant. Read SEC document |
| March 06, 2025 Filed Mar 8, 2025 00:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007457 · form4-03082025_120324.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,325 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025. Read SEC document |
| March 06, 2025 Filed Mar 8, 2025 00:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 7,008 | $0.39 | $2,733.12 |
DisclosureSEC source: 0001415889-25-007457 · form4-03082025_120324.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,544 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 01:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,792 | $0.34 | $955.14 |
DisclosureSEC source: 0001415889-24-028742 · form4-12092024_081201.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,552 F1 · shares: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of restricted stock units. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 00:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 17,395 | $0.39 | $6,784.05 |
DisclosureSEC source: 0001415889-24-023088 · form4-09092024_080901.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,344 F1 · shares: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of restricted stock units. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 23:00 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 19,289 | $1.19 | $22,953.91 |
DisclosureSEC source: 0001415889-24-016080 · form4-06072024_070604.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,739 F1 · shares: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of restricted stock units. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:17 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 422 | $1.87 | $789.14 |
DisclosureSEC source: 0001415889-24-007451 · form4-03092024_120348.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,028 F3 · shares: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:17 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007451 · form4-03092024_120348.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,450 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2024. Read SEC document |
| March 06, 2024 Filed Mar 9, 2024 00:17 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 23,168 | $1.87 | $43,324.16 |
DisclosureSEC source: 0001415889-24-007451 · form4-03092024_120348.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,669 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 21, 2024 Filed Feb 24, 2024 01:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 143,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001415889-24-005154 · form4-02242024_010252.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,000 Underlying: Common Stock · 143,000 shares Expires 2034-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2024 Filed Feb 24, 2024 01:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 29,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-005154 · form4-02242024_010252.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, CHINA OPERATIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,837 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2025, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 06, 2023 Filed Dec 11, 2023 21:20 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 18,182 | $0.58 | $10,545.56 |
DisclosureSEC source: 0001209191-23-058052 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,837 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2023 Filed Sep 8, 2023 20:58 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,308 | $0.96 | $3,185.93 |
DisclosureSEC source: 0001209191-23-048808 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 353,019 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 23:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001209191-23-048029 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2033-08-29 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on August 30, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 23:37 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 120,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-048029 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,327 F1 · shares: Represents the grant of restricted stock units (RSUs) that vest quarterly over one year from September 6, 2023. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 00:17 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,000 | $17.46 | $17,460.00 |
DisclosureSEC source: 0001209191-23-037604 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 236,327 F1 · shares: Shares sold pursuant to a 10b5-1 trading plan. F4 · price: The shares were sold at prices ranging from $17.37 to $17.61. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 00:17 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,250 | $16.66 | $87,465.00 |
DisclosureSEC source: 0001209191-23-037604 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 237,327 F1 · shares: Shares sold pursuant to a 10b5-1 trading plan. F3 · price: The shares were sold at prices ranging from $16.34 to $17.32. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 13, 2023 Filed Jun 16, 2023 00:17 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 6,250 | $17.60 | $110,000.00 |
DisclosureSEC source: 0001209191-23-037604 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 242,577 F1 · shares: Shares sold pursuant to a 10b5-1 trading plan. F2 · price: The shares were sold at prices ranging from $17.31 to $18.18. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 23:38 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,532 | $17.04 | $26,101.60 |
DisclosureSEC source: 0001209191-23-036064 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,827 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 23:38 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 739 | $17.04 | $12,589.83 |
DisclosureSEC source: 0001209191-23-036064 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,359 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 23:38 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,362 | $17.04 | $23,202.08 |
DisclosureSEC source: 0001209191-23-036064 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,098 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| April 04, 2023 Filed Apr 6, 2023 20:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 6,590 | $18.78 | $123,785.24 |
DisclosureSEC source: 0001209191-23-023591 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,460 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:58 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,914 | $20.20 | $58,854.93 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,050 F5 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU TSR previously reported in Table I. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:58 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 4,692 | $20.20 | $94,765.73 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,964 F4 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of PSU Milestone previously reported in Table I. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:58 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 9,338 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,656 F3 · shares: Represents the number of shares released for PSU TSR Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:58 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 5,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,318 F2 · shares: Represents the number of shares released for PSU Milestone Grant vested on March 8, 2023. Read SEC document |
| March 08, 2023 Filed Mar 11, 2023 02:58 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 8,354 | $21.16 | $176,736.39 |
DisclosureSEC source: 0001209191-23-018065 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,519 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:39 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $22.60 | $0.00 |
DisclosureSEC source: 0001209191-23-012426 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2033-02-20 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 01:39 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012426 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,873 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 08, 2022 Filed Dec 10, 2022 00:22 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,096 | $15.79 | $17,305.84 |
DisclosureSEC source: 0001209191-22-060582 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,705 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| December 08, 2022 Filed Jan 4, 2023 23:35 UTC Amendment | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,595 | $15.79 | $40,975.05 |
DisclosureSEC source: 0001209191-23-001354 · doc4a.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,873 F1 · shares: Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:30 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 4,683 | $13.01 | $60,925.83 |
DisclosureSEC source: 0001209191-22-052392 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,801 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2022 Filed Sep 8, 2022 22:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 518 | $12.26 | $6,350.68 |
DisclosureSEC source: 0001209191-22-049225 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,484 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 06, 2022 Filed Jan 4, 2023 23:33 UTC Amendment | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,851 | $12.26 | $22,693.26 |
DisclosureSEC source: 0001209191-23-001351 · doc4a.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,151 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 23:24 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 1,850 | $9.50 | $17,575.00 |
DisclosureSEC source: 0001209191-22-035220 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,002 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 23:29 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 4,682 | $12.02 | $56,277.64 |
DisclosureSEC source: 0001209191-22-022097 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,852 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 22:45 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,905 | $12.69 | $49,554.45 |
DisclosureSEC source: 0001209191-22-017649 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,534 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 01:59 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0001209191-22-010449 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-13 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 01:59 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010449 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,439 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:41 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 5,284 | $14.82 | $78,308.88 |
DisclosureSEC source: 0001209191-22-001740 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,439 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 21:02 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,668 | $14.19 | $37,858.92 |
DisclosureSEC source: 0001209191-21-068506 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,723 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 23:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 32,360 | $0.00 Strike: $9.93 | $0.00 |
DisclosureSEC source: 0001209191-21-059871 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,360 Underlying: Common Stock · 32,360 shares Expires 2031-10-04 F2 · derivative.exercise_date: Fifty percent of the shares subject to the option vests on each September 30, 2022 and March 31, 2023. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 23:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 54,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059871 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,391 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on each December 31, 2021, March 31, 2022, September 30, 2022 and March 31, 2023. Read SEC document |
| September 07, 2021 Filed Sep 10, 2021 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,030 | $12.41 | $25,192.30 |
DisclosureSEC source: 0001209191-21-055403 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,251 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:26 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 2,030 | $22.90 | $46,487.00 |
DisclosureSEC source: 0001209191-21-039293 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,251 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 684 shares acquired on May 14, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:32 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 5,679 | $33.37 | $189,508.23 |
DisclosureSEC source: 0001209191-21-019549 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,597 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:21 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 41,700 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001209191-21-015006 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 Underlying: Common Stock · 41,700 shares Expires 2031-02-24 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:21 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 21,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015006 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,276 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:27 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,039 | $41.99 | $127,607.61 |
DisclosureSEC source: 0001209191-20-062615 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,576 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 08, 2020 Filed Sep 10, 2020 23:28 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,038 | $42.16 | $128,082.08 |
DisclosureSEC source: 0001209191-20-050046 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,615 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.